Duvic M. Histone deacetylase inhibitors: SAHA (Vorinostat). A treatment option for advanced cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2024 May 7];2(5). Available from: https://www.pagepress.org/journals/hmr/article/view/724